Drug registration in South Korea is governed primarily by the Pharmaceutical Affairs Act, which outlines the approval process, safety standards, and quality control measures. Additional regulations include the Bioethics and Safety Act and the Korean Good Manufacturing Practice (GMP) guidelines, ensuring compliance and protecting public health in pharmaceutical development and distribution.